Ottawa, ON /Business Wire/ February 22, 2022 /– Avivagen Inc.  (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance, is pleased to announce that Avivagen’s oxidized carotenoid-based feed additive product has received approval for use in Vietnam.

“We are very excited to secure approval for our product in Vietnam, a critical feed market in Southeast Asia with strong growth potential over the coming years,” says Kym Anthony, Chief Executive Officer, Avivagen.  “We continue to make strong in-roads with feed producers across Asia and see considerable opportunity to further grow our presence in the swine and poultry feed markets in Vietnam and across the region.”

Vietnam represents the largest feed market in Southeast Asia according to a report by the US Grains Council, which indicates total annual feed consumption of over 32 MMT in 2020. Additionally, The Grains Council report states that Vietnam is a strong growth market which is expected to surpass 35 MMT of feed within the next few years.[i] Production within the country is dominated by swine, with feed for swine accounting for approximately 38% of total feed, followed by poultry accounting for 21.6% of total feed. (2020)[ii]. In addition to swine and poultry Vietnam has a surprisingly large and rapidly growing dairy industry which represents an important third target market segment for use of Avivagen’s product.

“Demand for effective alternatives to antibiotics is growing across all of Southeast Asia,” says Lesley Nernberg, Technical Sales and Marketing Consultant, Asia, Avivagen Inc. “Approval in Vietnam will allow Avivagen to capitalize on a marketplace ready for these types of innovations.”

The use of Avivagen’s product in the Vietnam feed industry is supported by the positive results of two research trials conducted specifically under Vietnamese commercial production conditions. The trials were run in collaboration with the Institute for Animal Sciences for South Vietnam and were conducted with pigs. “The results of these two trials make clear the benefits of Avivagen’s product on improving the health and productivity of piglets. We’re confident that the use of our product in this segment, along with poultry and dairy, will have a significantly positive impact for producers throughout the country,” says Jamie Nickerson, President, Avivagen Inc. “Comparable trials are underway around the world, and we expect many to result in additional regulatory approvals and customer wins over the coming months.”

About Avivagen

Avivagen is a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance.  It is a public corporation traded on the TSX Venture Exchange under the symbol VIV and is headquartered in Ottawa, Canada, based in partnership facilities of the National Research Council of Canada. For more information, visit www.avivagen.com. The contents of the website are expressly not incorporated by reference in this press release.

About OxC-beta™ Technology and OxC-beta™ Livestock

Avivagen’s OxC-beta™ technology is derived from Avivagen discoveries about β-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colours. Through support of immune function the technology provides a non-antibiotic means of promoting health and growth. OxC-beta™ Livestock is a proprietary product shown to be an effective and economic alternative to the antibiotics commonly added to livestock feeds. The product is currently available for sale in the United States, Philippines, Mexico, Taiwan, New Zealand, Thailand, Brazil, Australia, and Malaysia.

Avivagen’s OxC-beta™ Livestock product is safe, effective and could fulfill the global mandate to remove all in-feed antibiotics as growth promoters. Numerous international livestock trials with poultry and swine using OxC-beta™ Livestock have proven that the product performs as well as, and, sometimes, in some aspects, better than in-feed antibiotics.

Forward Looking Statements
This news release includes certain forward-looking statements that are based upon the current expectations of management. Forward-looking statements involve risks and uncertainties associated with the business of Avivagen Inc. and the environment in which the business operates. Any statements contained herein that are not statements of historical facts may be deemed to be forward-looking, including those identified by the expressions “aim”, “anticipate”, “appear”, “believe”, “consider”, “could”, “estimate”, “expect”, “if”, “intend”, “goal”, “hope”, “likely”, “may”, “plan”, “possibly”, “potentially”, “pursue”, “seem”, “should”, “whether”, “will”, “would” and similar expressions.

Statements set out in this news release relating to the future growth and prospects for Avivagen, benefits to Avivagen resulting from receipt of regulatory approval, the benefits to customers from the use of Avivagen’s products, Avivagen’s expectations as to the results of ongoing trials, the potential for additional regulatory approvals and the possibility for OxC-beta™ Livestock to replace antibiotics in livestock feeds as growth promoters are forward-looking statements. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. For instance, Avivagen’s products may not gain market acceptance or regulatory approval in new jurisdictions or for new applications and may not be widely accepted as a replacement for antibiotics as growth promoters in livestock feeds due to many factors, many of which are outside of Avivagen’s control.  Readers are referred to the risk factors associated with the business of Avivagen set out in Avivagen’s most recent management’s discussion and analysis of financial condition available at www.SEDAR.com. Except as required by law, Avivagen assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward-looking statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For more information:
Avivagen Inc.
Drew Basek
Director of Investor Relations
100 Sussex Drive, Ottawa, Ontario, Canada K1A 0R6 Phone: 416-540-0733
E-mail: d.basek@avivagen.com
Kym Anthony
Chief Executive Officer
100 Sussex Drive, Ottawa, Ontario, Canada K1A 0R6 Head Office Phone: 613-949-8164
Website: www.avivagen.com


[i] https://grains.org/markets-tools-data/markets/market-profiles/vietnam/

[ii] https://public.tableau.com/app/profile/alltech.digital/viz/AlltechGlobalFeedSurvey2021/AlltechGlobalFeedSurvey2021

47 Responses

  1. sumycin marcas de ivermectina en mexico LONDON, Sept 25 Reuters World shares dipped for a fourthstraight day on Wednesday and the dollar struggled as worriesover a possible government shutdown in Washington and mixedsignals on U precio priligy 30 mg Drug ranking based on drug positivity scores

  2. com 20 E2 AD 90 20Effet 20Indsirable 20Viagra 20Homme 20 20A 20Road 20To 20Viagra 20Episode 202 effet indsirable viagra homme Atos Healthcare said in a statement We are sorry when we do not meet our own high standards but can reassure that a C grade report does not mean the assessment was wrong and there are checks and balances throughout the system so that the correct decision on benefit is made by the department most reliable site to buy clomid

  3. com 20 E2 AD 90 20Buy 20Viagra 20Abroad 20 20Viagra 20Maroc viagra maroc A history buff who majored in political science Гў Гў I never finished college, which, whatever, this is better, Гў he jokes Гў listening to Francesa has become a borderline obsession for Buchanan, and some of the PontiffГў s idiosyncrasies have made their way into BuchananГў s everyday routine stromectol vente libre

  4. Gams said, whereas we anticipated 40 to 50 response rates lasix overdose The monoclonal antibody NZ 1 directed against podoplanin disrupted both the podoplanin CLEC 2 interaction and podoplanin induced pulmonary metastasis 231

  5. Federal, Provincial and Territorial Advisory Committee on Population Health Mammograms and breast examinations clomid dosing pct Flag RNF208 or Myc RNF208 was subcloned into the Xho I and Cla I sites of the LPCX vector NIH, resulting in LPCX Flag RNF208 or LPCX Myc RNF208, respectively

  6. The study by Chae and colleagues 30, which was previously cited on ACEI ARB, also evaluated the association with statin use and reported a decrease risk of recurrence multivariate hazard ratio HR 0 reddit priligy Nine pregnancies in six beagle bitches were used for the present study

  7. glabrous skin regions but instead seems to correlate with regions located at the extremities priligy for sale In the Bland Altman plots, the y axis is the difference between both measurements and the x axis is the average of the two measurements

  8. There was no cell death in these pancreata, suggesting that the remaining YAP epithelial cells generated sufficient secreted CTGF and or other secreted factors to maintain cell survival lasix sat?n These observations could be due to interference of normal GATA factor functions in the skin as a result of induced myc GATA 6 overexpression 17, 18

  9. What’s up everyone, it’s my first visit at this website, and article is genuinely fruitful
    in favor of me, keep up posting these types
    of posts.

  10. Buy Januvia online without a prescription Where can I find the best deals on diabetes
    medication online without a prescription?
    Where to buy cheap insulin online without a damn prescription Looking for a dark web
    pharmacy that sells Acarbose at a discount?

  11. Thanks for a marvelous posting! I seriously enjoyed reading it, you happen to be a great author.I will always bookmark your blog and will often come back later
    on. I want to encourage yourself to continue your great posts,
    have a nice holiday weekend!

  12. Today, I went to the beach with my kids. I found a sea shell and gave
    it to my 4 year old daughter and said “You can hear the ocean if you put this to your ear.”
    She placed the shell to her ear and screamed.
    There was a hermit crab inside and it pinched her ear.
    She never wants to go back! LoL I know this is entirely off topic but I had to tell someone!

  13. To compare furosemide with anabolic steroids in other sports is inappropriate buying cialis online On the basis of previous follow up, 22 the most common causes of death in the entire cohort are known to be cancer, coronary heart disease, and stroke

  14. Have you ever thought about creating an ebook or guest authoring on other sites?

    I have a blog based upon on the same subjects
    you discuss and would really like to have you share
    some stories/information. I know my viewers would appreciate your work.
    If you’re even remotely interested, feel free to shoot me an email.

Leave a Reply

Your email address will not be published.